AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for slowing kidney disease progression
Disease control OngoingThis study is testing whether a diabetes drug called empagliflozin is safe and can help slow the progression of a genetic kidney disease called ADPKD. It involves 44 adults with rapidly progressing disease, some of whom are already taking the standard medication. Researchers will…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY
Phase: PHASE4 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors dig through old records to find clues for slowing kidney disease
Knowledge-focused OngoingThis study aims to understand what patient characteristics can predict how quickly kidney function declines in people with a genetic kidney disease called ADPKD. Researchers will look back at the medical records of 70 patients who already received a specific long-term treatment c…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC